|Bid||64.57 x 400|
|Ask||65.72 x 100|
|Day's Range||65.04 - 65.40|
|52 Week Range||58.29 - 66.80|
|PE Ratio (TTM)||35.29|
|Earnings Date||Oct 27, 2017|
|Dividend & Yield||1.88 (2.85%)|
|1y Target Est||70.11|
Merck's (MRK) Keytruda received FDA approval for advanced gastric cancer, making it the tenth new indication approved for Keytruda.
Hackers have learned to compromise software supply chains.
Apple, UnitedHealth, Walmart, and Merck led the losers among the Dow 30 stocks on Friday.